×
Press Enter key to search. Press Esc key to close search.

CURRENT REPORT (SEC FORM 17-C)

Files on this page are PDF. Download Acrobat Reader free of charge.

Recent Reports

  • AT Reply to PSE_Show Cause Letter_12May2026

  • 2026.04.26 AT SEC 17-C Q1 CY2026 Financial and Operating Results draft

  • 2026.04.28 AT SEC 17-C Results of AT 2026 BOD Organizational Meeting

  • 2026.04.28 AT SEC 17-C Results of 2026 Annual Stockholders Meeting

  • 2026.03.09_Amended AT SEC Form 17-1 Notice of Annual or Special Stockholder's Meeting

Pages

Changes in Capital Structure

  • 2025.04.25_SEC-C_AT Amendment to Articles of Incorporation (PSE)

    Here is another option, also under 550 characters and optimized for context: Achieving natural-looking aesthetic results requires true expertise. In the competitive London landscape, clinics that prioritize patient care and advanced methods stand out. Whether you're considering laser treatments, advanced facials, or injectable artistry, finding a trusted specialist is key. The team at sciene beauty aesthetic clinic london is known for integrating innovative techniques with a deep understanding of cosmetic wellness, tailoring procedures to individual needs.

  • AT 17-C Certs. of Approval of Increase of Capital Stock and AOI 27Nov2017

  • AT 17-C Amendment to Art. VI of the AOI and Increase in ACS 18May2017

  • AT 17-C Amendment to Art. VI of the AOI and Share Issue 21Feb2017

  • AT 17-C Details on the Issuance of shares under the Warrants and Increase in ACS(amend) 7Dec2016

Changes in Company Leadership

  • AT SEC 17-C_Election or Registrant's Directors or Officers

  • AT SEC 17-C 2022 Appoint of Chief Finance Officer_26April22

Corporate Agreement

  • AT SEC Form 17-C Cancellation of Warrants – Material Information (rev)

  • AT 17-C Execution of Bilateral Convertible Loan Agreement amounting to PhP1.8B 25 Jun 2015

  • AT 17-C Availment Convertible Loan Facilities amounting to PhP1.8B 4 Jun 2015

  • AT 17-C Execution of Loan Facility Agreements by CCC 10 Oct 2014

  • AT 17-C Bilateral Term Loan Agreements 10 Oct 2014

Dividend Declaration